Molecular markers (c-erbB-2, p53) in breast cancer.

Molecular markers (c-erbB-2, p53) in breast cancer.

The aim of our study was to evaluate the correlation between clinical characteristics, histopatologic features and c-erbB-2 as well as p53 expression in cancer tissues. Breast cancer tissue was obtained from 184 female subjects with primary breast cancer. According to hormonal status patients were d...

Full description

Bibliographic Details
Main Authors:	Piotr Zukrowski, Zygmunt Grzebieniak, Jerzy Rudnicki, Michał Jeleń, Anil Kumar Agrawal, Ewa Nienartowicz
Format:	Article
Language:	English
Published:	Via Medica 2009-01-01
Series:	Folia Histochemica et Cytobiologica
Online Access:	http://czasopisma.viamedica.pl/fhc/article/view/4403

Similar Items

Androgen receptors as a prognostic and predictive factor in breast cancer.
by: Jerzy Rudnicki, et al.
Published: (2008-12-01)

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
by: Sathish Kumar Mungamuri, et al.
Published: (2013-10-01)

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020-06-01)

Proteolytic processing of ErbB4 in breast cancer.
by: Maija Hollmén, et al.
Published: (2012-01-01)

Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK.
by: Yong-Liang Yao, et al.
Published: (2013-01-01)

Treatment of ErbB2 breast cancer by mitochondrial targeting
by: Sophia Eldad, et al.
Published: (2020-07-01)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
by: Meysam Moghbeli, et al.
Published: (2019-01-01)

Expression of c-erbB3 protein in primary breast carcinomas.
by: Naidu, R., et al.
Published: (1998)

Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
by: Yoon Sin Oh, et al.
Published: (2011-01-01)

Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis
by: Yun Liu, et al.
Published: (2023-05-01)

The role of protease activity in ErbB biology.
by: Blobel, C, et al.
Published: (2009)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
by: Mizobuchi S, et al.
Published: (2013-02-01)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
by: Ghazaleh Moshkdanian, et al.
Published: (2017-06-01)

Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients
by: Singh Usha, et al.
Published: (2006-05-01)

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
by: Tingting Lin, et al.
Published: (2019-04-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
by: Evelina Miele, et al.
Published: (2020-02-01)

Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Cell Regeneration
by: Young-Sun Lee, et al.
Published: (2021-01-01)

Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast
by: Marcus Vinicius Martins de Menezes, et al.

Computational modeling of ErbB kinase oligomeric state.
by: Lim, Sing Mei.
Published: (2010)

Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy
by: Deepak Mittal, et al.
Published: (2019-11-01)

Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India
by: Priya Kumar, et al.
Published: (2012-06-01)

c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.
by: Soomro, S, et al.
Published: (1993)

c-erbB-2 expression in different histological types of invasive breast carcinoma.
by: Soomro, S, et al.
Published: (1991)

Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models
by: Raman Devarajan, et al.
Published: (2023-09-01)

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
by: Schillaci Roxana, et al.
Published: (2012-02-01)

Expression of c-erbB-2, p53 and c-myc proteins in male breast carcinoma: Comparison with traditional prognostic factors and survival
by: M. Mourão Netto, et al.
Published: (2001-07-01)

Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
by: Wenle Xia, et al.
Published: (2014-01-01)

Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation
by: Worthington Jenny, et al.
Published: (2010-09-01)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
by: Gillian Farnie, et al.
Published: (2013-01-01)

Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma
by: Orlando Parise Junior, et al.

Structure-function analysis of nucleolin and ErbB receptors interactions.
by: Keren Farin, et al.
Published: (2009-01-01)

The Mysterious Ways of ErbB2/HER2 Trafficking
by: Vibeke Bertelsen, et al.
Published: (2014-08-01)

ErbB4 in the brain: Focus on high grade glioma
by: Jamie-Lee Pitcher, et al.
Published: (2022-08-01)

Role of C-erbB2 expression in gallbladder cancer
by: Niraj Kumari, et al.
Published: (2012-01-01)

Role of ErbB receptors in cancer cell migration and invasion
by: Aline eAppert-Collin, et al.
Published: (2015-11-01)

Identification of nucleolin as new ErbB receptors- interacting protein.
by: Ayelet Di Segni, et al.
Published: (2008-01-01)

Topological analysis of MAPK cascade for kinetic ErbB signaling.
by: Takashi Nakakuki, et al.
Published: (2008-01-01)

Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
by: Kranthi Kumar Chougoni, et al.
Published: (2023-11-01)

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
by: Flores Juana M, et al.
Published: (2010-07-01)